S100A7在肝内胆管细胞癌中的表达及其临床意义

doi:10.3969/j.issn.2095-378X.2021.01.002

外科研究与新技术 ›› 2021, Vol. 10 ›› Issue (1): 4-8.doi: 10.3969/j.issn.2095-378X.2021.01.002

S100A7在肝内胆管细胞癌中的表达及其临床意义

陆小亮, 吴彬, 陈科济, 李爱军, 范飞

海军军医大学附属东方肝胆外科医院特需治疗科三病区,上海 200438

收稿日期:2021-01-07 发布日期:2021-05-18
通讯作者: 范飞,电子信箱：178035587@qq.com
作者简介:陆小亮（1985—）,男,研究生,主治医师,从事临床肝胆外科工作
基金资助:
上海市嘉定区卫健委面上项目（2017-KY-02）

Expression of S100A7 in intrahepatic cholangiocarcinoma and its clinical significance

LU Xiaoliang, WU Bin, CHEN Keji, LI Aijun, FAN Fei

Department of The Third Ward of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China

Received:2021-01-07 Published:2021-05-18

摘要/Abstract

摘要： 目的探讨S100A7 在肝内胆管癌组织中的表达及其临床意义。方法收集东方肝胆外科医院2018年1月—2020年1月经病理证实的30例肝内胆管癌标本,应用免疫组化、免疫印迹、PCR方法检测S100A7在肝内胆管癌细胞中的表达水平。结果肝内胆管癌S100A7表达阳性百分比明显高于癌旁组织（50%对10%, P<0.05）。S100A7表达与肿瘤浸润深度、淋巴结转移、TNM分期呈显著正相关（P<0.05）,但与患者患者性别、年龄、淋巴管侵犯、肿瘤分化程度、远处转移无关。结论肝内胆管癌S100A7高表达,可能有助于预测肝内胆管癌患者的预后。

关键词: 肝内胆管癌, S100A7, 预后

Abstract: Objective To observe the expression of S100A7 in intrahepatic cholangiocarcinoma （ICC） and its clinical significance. Methods Tissue specimens from 30 cases of pathologically proven ICC were collected in the Eastern Hepatobiliary Surgery Hospital from January 2018 to January 2020. The expression of S100A7 in ICC tissue was analyzed by immunohistochemistry, Western blotting and PCR. Results The S100A7 level expressed in ICC tissue was significantly higher than that in para-carcinoma （50% vs. 10%, P<0.05）.The expression of S100A7 was correlated with the depth of tumor invasion, lymph node metastasis and TNM stage （all P<0.05）, but not correlated with the patient's sex, age, lymphatic invasion, tumor differentiation and distant metastasis. Conclusion S100A7 is overexpressesd in ICC, which is helpful to evaluate the prognosis of patients with ICC.

Key words: Intrahepatic cholangiocarcinoma, S100A7, Prognosis

中图分类号:

R656

陆小亮, 吴彬, 陈科济, 李爱军, 范飞. S100A7在肝内胆管细胞癌中的表达及其临床意义[J]. 外科研究与新技术, 2021, 10(1): 4-8.

LU Xiaoliang, WU Bin, CHEN Keji, LI Aijun, FAN Fei. Expression of S100A7 in intrahepatic cholangiocarcinoma and its clinical significance[J]. Surgical Research and New Technique, 2021, 10(1): 4-8.

参考文献

[1] Akateh C, Ejaz AM, Pawlik TM, et al, Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma[J]. World J Hepatol, 2020,12(10):693-708.
[2] Khan AS, Dageforde LA, Cholangiocarcinoma[J]. Surg Clin North Am, 2019,99(2):315-335.
[3] Massarweh NN, El-Serag HB, Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Cancer Controll, 2017,24(3):1073274817729245.
[4] Blechacz B, Komuta M,Roskams T, alet, Clinical diagnosis and staging of cholangiocarcinoma[J]. Nat Rev Gastroenterol Hepatol,2011,8(9):512-522.
[5] Thorsen MK, Quiroz F, Lawson TL, et al.Primary biliary carcinoma: CT evaluation[J]. Radiology, 1984,152(2):479-483.
[6] Yang XQ, Xu YF, Guo S, et al.Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma[J]. WJG, 2014,20(14):4076-4084.
[7] Ariizumi S, Kotera Y, Katagiri S, et al.Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy[J]. Ann Surg Oncol, 2014,21(Suppl 3):451-458.
[8] Luo X, Yuan L, Wang Y, et al.Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study[J]. J Gastrointest Surg, 2014,18(3):562-572.
[9] He CB,Zhang Y, Song Y, et al.Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma[J]. Cancer, 2018,9(17):3117-3128.
[10] Rangaraj A,Ye L, Sanders AJ, et al.Molecular and cellular impact of psoriasin (S100A7) on the healing of human wounds[J]. Exp Ther Med,2017,13(5):2151-2160.
[11] Donato R.S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles[J]. Int J Biochem Cell Biol, 2001,33(7):637-668.
[12] De Cid R, Riveira-Munoz E, Zeeuwen Patrick LJM, et al.Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis[J]. Nat Gene ,2009,41(2):211-215.
[13] Bresnick AR.S100 proteins as therapeutic targets[J]. Biophys Rev, 2018,10(6):1617-1629.
[14] Brodersen DE, Nyborg J, Kjeldgaard M.Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca²+-bound human psoriasin (S100A7) in the Zn²+-loaded and Zn²+-free states[J]. Biochemistry, 1999,38(6):1695-1704.
[15] Fan JJ, Hsu WH, Lee KH,et al.Dietary flavonoids luteolin and quercetin inhibit migration and invasion of squamous carcinoma through reduction of Src/Stat3/S100A7 signaling[J]. Antioxidants (Basel), 2019,8(11):557.
[16] Tian T,Li XK,Hua Z, et al.S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition[J]. Oncotarget, 2017,8(15):24964-24977.
[17] Sakurai M, Miki Y, Takagi K, et al.Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment[J]. Breast Cancer Res,2017,19(1):70.
[18] Wang R, Li YG, Hu Enze HU, et al.S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells[J]. Oncotarget, 2017,8(15):24804-24814.
[19] Sneh A, Deol YS, Ganju A, et al.Differential role of psoriasin (S100A7) in estrogen receptor alpha positive and negative breast cancer cells occur through actin remodeling[J]. Breast Cancer Res Treat, 2013,138(3):727-739.
[20] Deol YS, Nasser MW, Yu L, et al.Tumor-suppressive effects of psoriasin (S100A7) are mediated through the beta-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells[J]. J Biol Chem, 2011,286(52):44845-44854.
[21] Fan F, Lu JJ, Yu WL,et al.MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7[J]. Oncol Lett,2018,15(1):386-392.

S100A7在肝内胆管细胞癌中的表达及其临床意义

Expression of S100A7 in intrahepatic cholangiocarcinoma and its clinical significance

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

编辑推荐

Metrics

本文评价

[1]	颜海蓝. NOSES术治疗左半结肠癌的疗效及预后影响因素分析[J]. 外科研究与新技术, 2020, 9(4): 228-230.
[2]	周灿宦, 李红全, 李立, 谭超华. 乳腺叶状肿瘤的临床病理特征及其与预后的关系[J]. 外科研究与新技术, 2020, 9(4): 231-233.
[3]	金海龙, 武彪, 张毅. 乳腺癌术后患者不同局部区域复发对预后的影响[J]. 外科研究与新技术, 2020, 9(3): 149-153.
[4]	刘建新, 王正, 李建. 改良椎间孔镜手术治疗对腰椎间盘突出症患者疗效、手术结局及预后的影响[J]. 外科研究与新技术, 2020, 9(3): 166-169.
[5]	贺雪, 殷佩浩. 结直肠癌患者血清miR-21检测的临床价值[J]. 外科研究与新技术, 2019, 8(1): 1-3.
[6]	刘鹏飞, 刘凯, 叶春, 徐雯. 肝内胆管结石合并肝内胆管癌的外科诊治[J]. 外科研究与新技术, 2017, 6(2): 91-93.
[7]	顾向森周凯何小勇张杨杨周悦. 食管癌脉管瘤栓的相关因素分析[J]. 外科研究与新技术, 2016, 5(2): 108-110.
[8]	唐翀姜湉高雪松施文秦炜颜孙永强. 结直肠癌中ADAM-9的表达与预后的关系[J]. 外科研究与新技术, 2015, 4(4): 223-225.
[9]	范跃祖. 从胆囊癌的一种新血供方式---血管生成拟态看胆囊癌诊疗观点改变[J]. 外科研究与新技术, 2014, 3(3): 161-168.
[10]	范跃祖,孙伟,张文忠,葛春燕. 基质金属蛋白酶-1和膜型1基质金属蛋白酶在胆囊癌血管生成拟态中的表达及临床意义[J]. 外科研究与新技术, 2014, 3(1): 8-16.
[11]	孙伟，范跃祖，张文忠，葛春燕. 生成拟态和不良预后的意义[J]. 外科研究与新技术, 2013, 2(2): 73-86.
[12]	孙伟, 范跃祖, 张文忠, 葛春艳. 胆囊癌血管生成拟态,缺氧诱导因子1α和血管内皮生长因子表达及其与临床预后的关系[J]. 外科研究与新技术, 2012, 1(1): 27-41.